Bremelanotide for Female Sexual Dysfunctions Responder Analyses From a Phase 2B Dose-Ranging Study

被引：5
|
作者：
DeRogatis, Leonard R. [1 ]
Edelson, Jeffrey [1 ]
Jordan, Robert [1 ]
Greenberg, Sally [1 ]
Portman, David J. [1 ]
机构：
[1] Maryland Ctr Sexual Hlth, Lutherville Timonium, MD USA
来源：
OBSTETRICS AND GYNECOLOGY | 2014年 / 123卷
关键词：
D O I：
10.1097/01.AOG.0000447289.23270.72
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：26S / 27S
页数：2
相关论文
共 50 条
  • [21] Results of a Phase 2b, dose-ranging study of ataluren (PTC124®) in nonsense mutation Duchenne/Becker muscular dystrophy (nmDBMD)
    Finkel, R.
    Wong, B.
    Bushby, K.
    Reha, A.
    Elfring, G. L.
    Miller, L. L.
    Babiak, J.
    Morsy, M. A.
    Peltz, S.
    Welch, E.
    Atkinson, L.
    NEUROMUSCULAR DISORDERS, 2010, 20 (9-10) : 656 - 657
  • [22] CONCORDANCE ANALYSIS OF PATIENTS DIAGNOSED USING DSM-IV-TR WITH DIAGNOSTIC CRITERIA FOR FEMALE SEXUAL INTEREST/ AROUSAL DISORDER FROM A PHASE 2B STUDY WITH BREMELANOTIDE
    Clayton, A.
    Spana, C.
    Jordan, R.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 396 - 397
  • [23] CONCORDANCE ANALYSIS OF PATIENTS DIAGNOSED USING DSM-IV-TR WITH DIAGNOSTIC CRITERIA FOR FEMALE SEXUAL INTEREST/AROUSAL DISORDER FROM A PHASE 2B STUDY WITH BREMELANOTIDE
    Clayton, A. H.
    Spana, C.
    Jordan, R.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 276 - 276
  • [24] Bimekizumab Maintenance of Response in Patients with Psoriatic Arthritis: 2-Year Results from a Phase 2b Dose-Ranging Study and Its Open-Label Extension
    Merola, Joseph
    Behrens, Frank
    Kivitz, Alan
    Mease, Philip
    McInnes, Iain
    Ink, Barbara
    Assudani, Deepak
    Joshi, Paulatsya
    Coarse, Jason
    Ritchlin, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [25] Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
    Papp, K. A.
    Menter, A.
    Strober, B.
    Langley, R. G.
    Buonanno, M.
    Wolk, R.
    Gupta, P.
    Krishnaswami, S.
    Tan, H.
    Harness, J. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (03) : 668 - 677
  • [26] Efficacy and safety of povorcitinib for extensive vitiligo: 52-week results from a double-blinded, placebo-controlled, dose-ranging phase 2b study
    Pandya, Amit G.
    Ezzedine, Khaled
    Passeron, Thierry
    van Geel, Nanja
    Brown, Kurt
    Santos, Leandro
    Erskine, Lois
    Wagya, Kofi
    Blauvelt, Andrew
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [27] Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
    Castro, Mario
    Wenzel, Sally E.
    Bleecker, Eugene R.
    Pizzichini, Emilio
    Kuna, Piotr
    Busse, William W.
    Gossage, David L.
    Ward, Christine K.
    Wu, Yanping
    Wang, Bing
    Khatry, Deepak B.
    van der Merwe, Rene
    Kolbeck, Roland
    Molfino, Nestor A.
    Raible, Donald G.
    LANCET RESPIRATORY MEDICINE, 2014, 2 (11): : 879 - 890
  • [28] Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial
    Sitbon, Olivier
    Skride, Andris
    Feldman, Jeremy
    Sahay, Sandeep
    Shlobin, Oksana A.
    Mclaughlin, Vallerie
    Ghofrani, Hossein-Ardeschir
    Langleben, David
    Parsley, Ed
    D'Souza, Gwyn
    Marmon, Tonya
    Kamau-Kelley, Watiri
    Jones, Renee
    Grewal, Ravi
    Wring, Steve
    Palacios, Michelle
    Naik, Himanshu
    Denning, Jill
    Lazarus, Howard M.
    Humbert, Marc
    LANCET RESPIRATORY MEDICINE, 2024, 12 (11): : 865 - 876
  • [29] Efficacy and safety of simtuzumab for the treatment of primary sclerosing cholangitis: results of a phase 2b, dose-ranging, randomized, placebo-controlled trial
    Muir, A.
    Goodman, Z.
    Levy, C.
    Janssen, H.
    Montano-Loza, A.
    Bowlus, C.
    Ding, D.
    Jia, C.
    McColgan, B.
    Myers, R.
    Subramanian, M.
    McHutchison, J.
    Manns, M.
    Chapman, R.
    Afdhal, N.
    Eksteen, B.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S73 - S73
  • [30] Effects of Encaleret on Corrected QT Interval in Autosomal Dominant Hypocalcemia Type 1: Early Results From an Ongoing Phase 2b, Open-Label, Dose-Ranging Study
    Hartley, Iris
    Gafni, Rachel
    Roszko, Kelly
    Pozo, Karen
    Collins, Michael T.
    Nemeth, Edward
    Sani-Grosso, Ramei
    Sridhar, Ananth
    Stapleton, Lyndsay
    Roberts, Mary Scott
    Fox, Jonathan
    CIRCULATION, 2021, 144
12345